Prognostic significance of Klotho expression in patients with renal cell carcinoma

Abstract

Introduction:

Various molecular markers have been investigated in renal cell carcinoma (RCC) without significant reliability. We analyzed Klotho (tumor suppressive protein) expression in RCC to investigate its association with tumor-stage, grade, disease-free-survival (DFS) and overall-survival (OS).

Methods:

Data of histologically confirmed patients of RCC with complete clinical follow-up were retrieved from Medical-Record-Library. Tissue sections of tumor and normal parenchyma were prepared from the blocks. Immunohistochemical studies for Klotho were done with commercially available kit (EPR6856, Ab181373; Abcam, Cambridge MA, USA). Klotho expression was scored between 0–3 and grouped into weak/absent (0, 1) and moderate/strong (2, 3). Tumors stages and grades were grouped into low stage (I and II) and high stage (III and IV) and into low grade (grade 1 and 2) and high grade (grade 3 and 4) according to WHO/ISUP grading. The histopathologists were blinded as to the clinical and follow-up data. Various prognostic factors were analyzed with respect to Klotho expression. Kaplan-Meier curves were created for DFS and OS.

Results:

Fifty-four patients of mean age 55.15 ± 13.34 years and M:F ratio of 1.8:1 were included. Normal renal tissue had strong expression of Klotho in all. In tumor tissue 20 (37%) had negative, 7 (13%) had weak, 14 (25.9%) had moderate and 13 (24.1%) had strong Klotho expression. Significantly more patients had absent/weak Klotho expression with higher grade (16/24 (66.7%) vs 7/25 (28%); p = 0.007), higher stage (22/33 (66%) vs 5/21 (23.8%); p = 0.002), LVI (12/14 (85.7%) vs 2/14 (14.3%); p = 0.002), sinus-fat-invasion (16/21 (76.2%) vs 5/21 (23.8%); p = 0.002), renal-vein-involvement (14/18 (77.8%) vs 4/18 (22.2%); p = 0.004), necrosis (17/26 (65.3%) vs 9/26 (34.6%); p = 0.029) and metastasis (8/9 (88.9%) vs 1/9 (11.1%); p = 0.01). Median DFS and OS were significantly lower in patients with weak/absent Klotho expression (12 vs 23 months, p = 0.023 and 15 vs 33 months, p = 0.006 respectively). Kaplan-Meier curves showed lower estimated DFS and OS in patients with weak/absent expression.

Conclusions:

We conclude that Klotho expression in renal tumor could be a good prognostic marker in patients with RCC.

Keywords

Renal cell carcinoma insulin-like growth factor-1 receptor transforming growth factor β hematoxylin and eosin disease-free-survival

Get full access to this article

View all access options for this article.

References

Ljungberg

Campbell

Cho

, et al The epidemiology of renal cell carcinoma. Eur Urol 2011; 60: 615–621.

Siegel

Miller

Jemal

. Cancer statistics, 2015. CA Cancer J Clin 2015; 65: 5–29.

Doi

Zou

Togao

, et al Klotho inhibits transforming growth factor-beta1 (TGF-beta1) signaling and suppresses renal fibrosis and cancer metastasis in mice. J Biol Chem 2011; 286: 8655–8665.

Pantuck

Zisman

Beldegrun

. The changing natural history of renal cell carcinoma. J Urol 2001; 166: 1611–1623.

Agnihotri

Kumar

Jain

, et al Renal cell carcinoma in India demonstrates early age of onset and a late stage of presentation. Indian J Med Res 2014; 140(5): 624–629.

Frank

Blute

Cheville

, et al An outcome prediction model for patients with clear cell renal cell carcinoma treated with radical nephrectomy based on tumor stage, size, grade and necrosis: the SSIGN score. J Urol 2002; 168(6): 2395–2400.

Moe

. Klotho as a potential biomarker and therapy for acute kidney injury. Nat Rev Nephrol 2012; 8(7): 423–429.

Creighton

Morgan

Gunaratne

, et al Comprehensive molecular characterization of clear cell renal cell carcinoma. Nature 2013; 499: 43–49.

Gigante

Lucarelli

Divella

, et al Soluble serum αKlotho is a potential predictive marker of disease progression in clear cell renal cell carcinoma. Medicine (Baltimore) 2015; 94(45): e1917.

10.

Kim

Hwang

Lkhagvadorj

, et al Klotho plays a critical role in clear cell renal cell carcinoma progression and clinical outcome. Korean J Physiol Pharmacol 2016; 20(3): 297–304.

11.

Gershman

Moreira

Thompson

, et al Renal cell carcinoma with isolated lymph node involvement: long-term natural history and predictors of oncologic outcomes following surgical resection. Eur Urol 2017; 72(2): 300–306.